INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2022

Synbiotic supplementation significantly improved several cardiometabolic and anthropometric indices in patients with metabolic syndrome.

A systematic review and meta-analysis evaluated five randomized controlled trials including 1049 participants with metabolic syndrome to assess the effects of synbiotic interventions. Synbiotic supplementation significantly reduced serum insulin (WMD -6.39 μU/mL), triglycerides (WMD -20.3 mg/dl), total cholesterol (WMD -7.8 mg/dl), LDL cholesterol (WMD -9.02 mg/dl), waist circumference (WMD -4.04 cm), body weight (WMD -4.3 kg), systolic blood pressure (WMD -1.8 mmHg), and IL-6 (WMD -0.2 pg/mL), while increasing HDL cholesterol (WMD 2.3 mg/dl). No significant effects were observed for fasting plasma glucose, HOMA-IR, BMI, diastolic blood pressure, heart rate, or C-reactive protein.

Study type
Systematic review and meta-analysis of RCTs
Who was studied
1049 participants with metabolic syndrome across 5 trials
What was measured
Lipid profile, insulin resistance, blood pressure, anthropometric parameters, and inflammatory markers

THE PAPER

Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.

Arabi SM, Bahrami LS, Rahnama I, Sahebkar A. Pharmacol Res, 2022.

PubMed 34999222 ↗DOI 10.1016/j.phrs.2022.106061 ↗

Heart & arteriesDiabetes & blood sugarBlood pressureGut & microbiomeWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.